期刊文献+

奥曲肽与易蒙停治疗5-氟脲嘧啶诱导的腹泻的临床对比观察 被引量:2

Comparalve Study of Octreotide and Loperamide in the Treatmentof 5-Fluorouracial-induced Diarrhea
下载PDF
导出
摘要 目的 :分别观察奥曲肽和易蒙停治疗 5 -氟脲嘧啶诱导的腹泻的疗效和腹泻完全的中位时间并行对比分析。方法 :30例 5 -氟脲嘧啶诱导的腹泻病人分为奥曲肽治疗组 (OCT组 ) 14例和易蒙停治疗组 (LOP组 ) 16 例 ,OCT组接受奥曲肽 10 0 μg皮下注射 8小时一次 ,LOP组接受易蒙停 4mg口服 1天 3次 ,观察腹泻完全缓解率和腹泻完全缓解的中位时间。结果 :OCT组的腹泻完全缓解率为 78 5 7% (11/ 14 ) ,LOP组为 4 3 75 % (7/ 16 ) ,二组比较有显著性差异 (P <0 0 5 ) ;DCT组腹泻完全缓解的中位时间为 3天 ,LOP组为 6 5天。结论 :奥曲肽用于治疗 5 -氟脲嘧啶诱导的腹泻 ,较易蒙停有更高的缓解率 ,能在更短的时间内缓解腹泻。 Objective: To observe the complete response rate of diarrhea and median time of response to oetreotide and loperamide in 5 - Fluorouracial- induced diarrhea. Method: 30 cases patients with 5 - Fluorouraeial- induced diarrhea are divided into octreotide group (OCT group 14) and loperamide group (LOP group 16) respectively. Result: The complete response rate of diarrhea is 78.57% (11/14) in OCT group and 43.75% (7/16) in LOP group. There was satatistically significant difference beaween these twe groups ( P 〈 0.05), The midian time of complete response was 3 day,s in OCT group and 6.5 day,s in LOP group. Conclusion: Oetveotide was more effect than loperamide in 5- Fluorouraeial- induced diarrhea, and may improve diarrhea in shirt period.
出处 《华西医学》 CAS 2005年第1期74-75,共2页 West China Medical Journal
关键词 5-氟脲嘧啶诱导的腹泻 奥曲肽 易蒙停 5- Fluorouraeial- induced diarrhea octreotide loperamide
  • 相关文献

参考文献3

  • 1Zidan J,Hain N,Beny A et al.Octreotide in the treatment of severe chemotherapy-induced diarrhea[J].Ann Oncol,2001,12(2):227-9.
  • 2Gebbia V,Carreca I,Testa A,et al,Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy[J].Anticancer Drugs,1993,4(4):443-5.
  • 3Panos G,Seefanos N,Athina C,et al.Octreotide Acetate in the treatment of Fluorouracil-induced diarrhea[J].The Oncologist,1998,3(1):50-53.

同被引文献22

  • 1Sanguineti G, Endres EJ, Parker BC, et al. Acute toxicity of whole-pelvis IMP.T in 87 patients with localizedprostate cancer[J]. Acta Oncol, 2008, 47(2):301-310.
  • 2Andreyev J, Ross P, Donnellan C, etal. Guidance on the management of diarrhea during cancer chemotherapy[J]. Lancet Oncol, 2014, 15(10):447-460.
  • 3Sun JX, Yang N. Role of octreotide in post chemotherapy and/or radiotherapy diarrhea: prophylaxis or therapy?[J].Asia Pac J Clin Oncol, 2014, 10(2):108-113.
  • 4Zidan J, Haim N, Beny A, et al. Octreotide in the treatment of severe chemotherapy induced diarrhea[J]. Ann Oncol, 2001, 1 2(2):227-229.
  • 5Bhattacharya S, Vijayasekar C, Worlding J, et al. Octreotide in chemotherapy induced diarrhea in colorectal cancer: a rewiew article[J]. Acta Gastroenterol 8elg, 2009, 72(3):289-295.
  • 6Muehlbauer PM, Thorpe D, Davis A, et al. Putting evidence into practice: evidencebased interventions to prevent, manage, and treat chemotherapy-and radiotherapy- induced diarrhea[J]. Clin J Oncol Nuts, 2009, 13(3):336-341.
  • 7Martenson JA, Halyard MY, Sloan JA,et al. Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of north central cancer treatment group N00CA[J]. Am J Hematol, 2008, 26(32):5248-5253.
  • 8Zachariah B, Gwede CK, James J, et al. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectaJ cancer: randomized RTOG trial 0315[J]. J Nat/Cancer Inst, 2010, 102(8):547-556.
  • 9Cascinu S, Stefano AF, Fedeli SL, et al. Octreotide versus Ioperamide in the treatment of fluorouracil-induced diarrhea: A randomized trial[J]. J C/in Oncol, 1993,11(1):148-151.
  • 10Nikou GC, Polyzos A, Kostalas G, et al. Octreotide administration and gut hormone levels in patients with chemotherapy-induced diarrhea (oOnly Abstract)U]. HellJ Castroenterol, 1994, 7(2):111-114.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部